Neoprobe Corporation
Neoprobe’s Second Phase 3 Lymphoseek Study Commences
Published in Drug Law Weekly, June 16th, 2009
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that a second multicenter Phase 3 study of Lymphoseek® (NEO3-06) has received investigational review board approval to begin enrollment of patients diagnosed with head and neck squamous cell carcinoma. The Phase 3 study will evaluate the efficacy of Lymphoseek to identify sentinel lymph nodes that may be predictive of determining whether a patient’s cancer has spread into the lymphatic system. The Phase 3 study has been registered on the national clinical trials website www.clinicaltrials.gov.
David Bupp, Neoprobe’s President and CEO, said,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-16)
More Articles from Drug Law Weekly
- Addiction Medicine
National Partnership to Meet, Evaluate Addiction Treatment as Component of New Justice Programs - Addiction Medicine
New addiction medicine research from King's College London, King's College London outlined - American Chemistry Council
California Senate Ignores Worldwide Body of Scientific Evidence and Votes to Limit Consumer Choice - ARIAD Pharmaceuticals, Inc.
ARIAD Announces Updates On NF-?B Patent Appeals - Article One Partners, Llc
Article One Partners Wins 'Startup of the Year' Top Award at Startup 2009 Conference - Berenato, White & Stavish, Llc
Bethesda-Based IP Firm Berenato, White & Stavish, LLC Announces Team Expansion - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
